regorafenib

SMAD family member 4 ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33224274 Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment. 2020 2
2 29211816 Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment. 2017 1